Spread of adenovirus to geographically dispersed military installations, May-October 2007

Emerging Infectious Diseases

Volumn 16, Issue 5, 2010, Pages 769-775

  Trei, Jill S ^a   Johns, Natalie M ^a   Garner, Jason L ^a   Noel, Lawrence B ^b   Ortman, Brian V ^b   Ensz, Kari L ^c   Johns, Matthew C ^a   Bunning, Michel L ^d   Gaydos, Joel C ^e  

^a United States Air Force School of Aerospace Medicine   (United States)

^b Vandenberg Air Force Base   (United States)

^c Sheppard Air Force Base   (United States)

^d Lackland Air Force Base ^*  (United States)

^e Armed Forces Health Surveillance Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOMESTIC CHEMICAL; INFLUENZA VACCINE;

ADENOVIRUS; ADENOVIRUS TYPE 14; ADOLESCENT; ADULT; ARTICLE; BODY ACHE; CHILL; CONTROLLED STUDY; COUGHING; ENTEROVIRUS; FATIGUE; FEMALE; GEOGRAPHIC DISTRIBUTION; HAND WASHING; HEADACHE; HEALTH SURVEY; HOSPITALIZATION; HUMAN; HYGIENE; INFECTION CONTROL; INFECTION PREVENTION; INFLUENZA; INFLUENZA VIRUS A; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NOSE CONGESTION; PAIN; PARAINFLUENZA VIRUS; PNEUMONIA; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT DISEASE; SORE THROAT; SYMPTOMATOLOGY; VIRUS CULTURE; VIRUS TRANSMISSION;

ADENOVIRUS INFECTIONS, HUMAN; ADENOVIRUSES, HUMAN; ADOLESCENT; ADULT; DISEASE OUTBREAKS; FEMALE; GEOGRAPHY; HUMANS; MALE; MILITARY PERSONNEL; PNEUMONIA, VIRAL; POPULATION SURVEILLANCE; REPUBLIC OF KOREA; TIME FACTORS; TRAVEL; UNITED STATES;

EID: 77951149116     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1605.091633     Document Type: Article

References (19)

1. Russell KL, Hawksworth BA, Ryan MAK, Strickler J, Irvine M, Hansen CJ, et al. Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004. Vaccine. 2006;24:2835-42. DOI: 10.1016/j.vaccine.2005.12.062
2. Friedman M, Grayston JT, Loosli CG, Pierce WE, Whiteside JE, Woolridge RL. Studies on acute respiratory illness in naval recruits, with emphasis on adenoviruses (APC-RI). J Infect Dis. 1956;99:182-7.
3. Berge TO, England B, Mauris C, Shuey HE, Lennette EH. Etiology of acute respiratory disease among service personnel at Fort Ord, California. Am J Hyg. 1955;62:283-94.
4. Pierce WE, Peckinpaugh RO, Frazier WE, Griffin JP, Greenberg BH, Jackson GG. Live and killed adenovirus vaccines for the prevention of acute respiratory disease in recruits. Antimicrob Agents Chemother. 1965;5:55-8.
5. Dudding BA, Topp FH Jr, Winter PE, Buescher EL, Lamson TH, Leibovitz A. Acute respiratory disease in military trainees: the adenovirus surveillance program, 1966-1971. Am J Epidemiol. 1973;97:187-98.
6. Blasiole DA, Metzgar D, Daum LT, Ryan MA, Jianguo W, Wills C, et al. Molecular analysis of adenovirus isolates from vaccinated and unvaccinated young adults. J Clin Microbiol. 2004;42:1686-93. DOI: 10.1128/JCM.42.4.1686-1693.2004
7. Gray GC, Goswami PR, Malasig MD, Hawksworth AW, Trump DH, Ryan MA, et al. Adult adenovirus infections: loss of orphaned vaccines precipitates military respiratory disease epidemics. For the Adenovirus Surveillance Group. Clin Infect Dis. 2000;31:663-70. DOI: 10.1086/313999
8. Metzgar D, Osuna M, Kajon AE, Hawksworth AW, Irvine M, Russell KL. Abrupt emergence of diverse species B adenoviruses at US military recruit training centers. J Infect Dis. 2007;196:1465-73. DOI: 10.1086/522970
9. Centers for Disease Control and Prevention. Acute respiratory disease associated with adenovirus serotype 14-four states, 2006-2007. MMWR Morb Mortal Wkly Rep. 2007;56:1181-4.
10. Evans AE, ed. Viral infections of humans, epidemiology and control, 3rd edition. New York: Plenum Publishing Corporation; 1991. p.77-94.
11. Fox JP, Brandt CD, Wassermann FE, Hall CE, Spigland I, Kogon A, et al. The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VI. Observations of adenovirus infections: Virus excretion patterns, antibody response, efficiency of surveillance, patterns of infection, and relation to illness. Am J Epidemiol. 1969;89:25-50.
12. Tate JE, Bunning M, Lu X, Panozzo C, Lott L, Su J, et al. Adenovirus 14 illness among basic military trainees, 2007. In: Program and abstracts of the International Conference on Emerging Infectious Diseases, Atlanta, GA, USA, 2008. Washington: American Society for Microbiology. p. 141.
13. Metzgar D, Osuna M, Yingst S, Rakha M, Earhart K, Elyan D, et al. PCR analysis of Egyptian respiratory adenovirus isolates, including identification of species, serotypes, and coinfections. J Clin Microbiol. 2005;43:5743-52. DOI: 10.1128/JCM.43.11.5743-5752.2005
14. Lyons A, Longfield J, Kuschner R, Straight T, Binn L, Seriwatana J, et al. A double-blind, placebo controlled study to evaluate the safety and immunogenicity of the new, live, oral type 4 and type 7 adenovirus vaccines. Vaccine. 2008;26:2890-8. DOI: 10.1016/j.vaccine.2008.03.037
15. van der Veen J, Prins A. Studies of the significance of the recall phenomenon in the antibody response to adenovirus vaccine and infection. J Immunol. 1960;84:562-8.
16. Binn LN, Sanchez JL, Gaydos JC. Emergence of adenovirus type 14 in US military recruits-a new challenge. J Infect Dis. 2007;196:1436-7. DOI: 10.1086/522969
17. Lyons A, Longfield J, Kuschner R, Straight T, Binn L, Seriwatana J, et al. A double-blind, placebo controlled study to evaluate the safety and immunogenicity of the new, live, oral type 4 and type 7 adenovirus vaccines. In: Program and abstracts of the VIIIth International Symposium on Respiratory Viral Infections, Kohala Coast, Hawaii, March 16-19, 2006:P-13.
18. Hilleman MR. Epidemiology and control by vaccination of adenovirus caused respiratory disease. Proceedings of the Sixth International Congress on Tropical Medicine and Malaria, September 5-13, 1958. Vol 5. Lisbon: Instituto de Medicina Tropical; 1959. p. 489-98.
19. McNeill KM, Benton FR, Monteith SC, Tuchscherer MA, Gaydos JC. Epidemic spread of adenovirus type 4-associated acute respiratory disease between U.S. Army installations. Emerg Infect Dis. 2000;6:415-9. DOI: 10.3201/eid0604.000419